Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

BCL6 promotes CCR2-driven CNS infiltration of encephalitogenic Th17 cells

6 days 6 hours ago
BCL6, a transcription factor central to T follicular helper (TFH) cell differentiation, has recently been identified as a key regulator of T cell-mediated neuroinflammation. While previous research has established a connection between Th17 cells and B cell responses in autoimmune diseases, most notably in experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis-the role of BCL6 in T cell subsets beyond TFH cells remains unclear. In this study, we explored the impact of T...
Gaurav Kumar

Out with the old, in with the new?

5 days 6 hours ago
No abstract
James R Couch

Nitrogen-containing FDA-approved drugs in 2025: synthesis, significance and therapeutic applications

5 days 6 hours ago
Nitrogen-containing heterocycles (N-Hets) are among the most prevalent and versatile structural motifs in pharmaceuticals, serving as key scaffolds in over 85% of biologically active small molecules. Their structural diversity and functional versatility have made them integral components of both U.S. Food and Drug Administration (FDA) approved and investigational drug molecules, modulating biological activity across a range of molecular targets. In 2025, the FDA approved 26 small-molecule drugs...
Chetna Jadala

Racial and Ethnic Disparities in Inpatient Outcomes of Tricuspid Transcatheter Edge-to-Edge Repair in the United States

5 days 6 hours ago
CONCLUSIONS: Racial and ethnic disparities in T-TEER outcomes are evident, with Black patients experiencing higher major and overall complications, and Black and Hispanic patients having prolonged hospitalizations. Further investigation into the specific factors and policies driving these disparities is crucial in striving for more equitable cardiovascular care among different racial and ethnic populations.
Waleed Alruwaili

Qualitative Interviews of Physicians Managing Patients With Methamphetamine-Associated Pulmonary Arterial Hypertension: Understanding the Unmet Medical Needs From a Provider Lens

5 days 6 hours ago
Limited guidance exists for the management of methamphetamine-associated PAH (Meth-APAH) and the experiences of physicians treating this population are not well documented. This study explored how physicians approach diagnosis and treatment and identified unmet needs in clinical care through structured interviews with 30 U.S. pulmonologists and cardiologists who manage patients with Meth-APAH. Physicians relied heavily on patient self-report to establish methamphetamine use; only 20% performed...
John F Kingrey

Pagination

  • Previous page ‹ Previous
  • Page 204
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies